Showing results (111-120 of 134) with videos related to
Sort By:
Pageof 14
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 12, 2012
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patientsM M Santoro, D Armenia, L Fabeni, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 1, 2016
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donorC Cerva, L Colagrossi, G Maffongelli, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 12, 2023
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individualsD Armenia, R Gagliardini, C Alteri, et al.HIV Medicine|June 30, 2016
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimensD Armenia, D Di Carlo, G Maffongelli, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequencesC Balotta, G Facchi, M Violin, et al.The Journal of Frailty & Aging|February 9, 2019
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected PersonsG Guaraldi, S Marcotullio, R Maserati, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029M Surdo, C Alteri, M C Puertas, et al.Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for AntiretroviralsM Violin, F Forbici, A Cozzi-Lepri, et al.The Journal of Infectious Diseases|September 28, 2001
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapyC F Perno, A Cozzi-Lepri, C Balotta, et al.The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenD Armenia, D Di Carlo, A Calcagno, et al.Pageof 14